CoreAge Rx and Mochi both market online access to care that may involve compounded tirzepatide. Their advertised payment structures differ, but an accurate comparison also needs the prescription, pharmacy, and follow-up arrangement.
CoreAge Rx receives paid featured placement on this site. We reviewed public information on September 23, 2026; we did not conduct a clinical head-to-head trial, enroll as patients, or score either service’s treatment outcomes.
The most useful comparison is two complete written offers for clinically appropriate care, not two starting prices.
Compare the same billing period
CoreAge’s linked offer advertises $149 monthly compounded tirzepatide, all doses at the same price, and no membership fee. Mochi’s FAQ lists $79 for a one-month membership plus compounded tirzepatide starting at $90, with medication cost varying by dose.
Adding Mochi’s two starting figures gives $169 as an illustrative one-month starting total, not a personalized quote. Longer membership options and different prescriptions can change the comparison. Our cost fieldnote lists the other items to confirm, including labs, supplies, and renewal terms.
Sources: CoreAge Rx: Current promotional offer · Mochi Health: Public care and pricing FAQs
Ask what access to care actually means
CoreAge describes clinical intake review and ongoing provider access. Mochi describes video visits, messaging, and plan-dependent support services. Those public descriptions do not establish the same appointment format, response time, or nutrition services.
Ask each service who will prescribe, when follow-up occurs, how urgent questions are handled, and what additional visits cost. If nutrition support matters to you, ask which professional provides it in the exact plan you are buying. Read the fuller CoreAge review and Mochi review for the source boundaries.
Sources: CoreAge Rx: Tirzepatide product page · Mochi Health: Public care and pricing FAQs
Do not treat compounded prescriptions as identical
Neither a shared ingredient nor similar marketing proves that two compounded preparations are equivalent. Ask for the formulation, concentration, pharmacy, storage requirements, and medical reason an approved product would not meet your needs.
CoreAge says it assigns a pharmacy after clinical review. For either service, verify the pharmacy actually handling your prescription and its relevant licensing. FDA’s compounding concerns deserve attention regardless of which company’s checkout looks simpler.
Sources: CoreAge Rx: Dispensing pharmacy FAQ · FDA: Concerns with unapproved GLP-1 drugs · FDA: Buying medicines from online pharmacies · FDA: GLP-1 supply and compounding policy
Read the exit conditions as carefully as the entry offer
Ask when recurring charges occur, how cancellation works, and what happens to an order already being prepared. Mochi’s public policy says prescription sales are final. Obtain the current order-specific rules from both services before paying, especially for a prepaid plan.
If an approved product is medically suitable, include that option in the clinical discussion rather than limiting research to these two brands. The LillyDirect review provides another route to investigate. Our notebook turns these comparison points into questions you can bring to a visit.
Sources: Mochi Health: Refunds · Mochi Health: Terms · FDA: Managing medicine benefits and risks · LillyDirect: Zepbound self-pay options
The source shelf
- CoreAge Rx: Current promotional offer
Advertised terms only; no checkout, prescription or pharmacy product was tested.
- Mochi Health: Public care and pricing FAQs
Membership, medication and insurance pathways must be distinguished.
- CoreAge Rx: Tirzepatide product page
Public product description; verify the selected offer and clinical eligibility.
- CoreAge Rx: Dispensing pharmacy FAQ
Provider description of pharmacy matching; actual dispensing pharmacy must be confirmed for an order.
- FDA: Concerns with unapproved GLP-1 drugs
Compounding, fraudulent labels, dosing errors and the limits of adverse-event reports. Checked September 23, 2026.
- FDA: Buying medicines from online pharmacies
Checks for prescription requirements, licensing, contact details and pharmacy support.
- FDA: GLP-1 supply and compounding policy
Shortage resolution and restrictions on essentially copies; availability requires current professional assessment.
- Mochi Health: Refunds
Cancellation and refund rules can differ for membership and a processed prescription.
- Mochi Health: Terms
Platform payment and service terms; read with the selected treatment agreement.
- FDA: Managing medicine benefits and risks
General questions for clinical decision-making and medication follow-up.
- LillyDirect: Zepbound self-pay options
Current prices vary by presentation and prescribed strength; higher-strength promotional pricing has refill timing conditions.
